PPWM
WST icon

PFG Private Wealth Management’s West Pharmaceutical WST Stock Holding History

PFG Private Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11
Closed -$2.46K – 255
2025
Q1 		$2.46K Hold
11
– – ﹤0.01% 224
2024
Q4 		$3.6K Hold
11
– – ﹤0.01% 171
2024
Q3 		$3.3K Hold
11
– – ﹤0.01% 184
2024
Q2 		$3.62K Hold
11
– – ﹤0.01% 172
2024
Q1 		$4.35K Hold
11
– – ﹤0.01% 158
2023
Q4 		$3.87K Hold
11
– – ﹤0.01% 167
2023
Q3 		$4.13K Hold
11
– – ﹤0.01% 228
2023
Q2 		$4.21K Hold
11
– – ﹤0.01% 237
2023
Q1 		$3.81K Hold
11
– – ﹤0.01% 239
2022
Q4 		$3K Hold
11
– – ﹤0.01% 275
2022
Q3 		$3K Hold
11
– – ﹤0.01% 288
2022
Q2 		$3K Hold
11
– – ﹤0.01% 276
2022
Q1 		$5K Sell
11
-226
-95% -$88.5K ﹤0.01% 224
2021
Q4 		$111K Sell
237
-5
-2% -$2.15K 0.06% 85
2021
Q3 		$103K Buy
+242
New +$102K 0.06% 68

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

PFG Private Wealth Management's WST Position: Q2 2025 in Review

PFG Private Wealth Management sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 11 shares — an estimated $2.46K sold.

PFG Private Wealth Management first reported a position in WST in Q3 2021 and held it in 15 quarters. The position peaked at $111K in Q4 2021. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • PFG Private Wealth Management reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • PFG Private Wealth Management sold 11 West Pharmaceutical shares in Q2 2025, an estimated $2.46K.
  • PFG Private Wealth Management first reported a position in West Pharmaceutical in Q3 2021 and held it in 15 quarters.
  • PFG Private Wealth Management's West Pharmaceutical position peaked at $111K in Q4 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on PFG Private Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.